Cancer Family

Genitourinary System Neoplasm

Non-malignant3,849 active trials61 approved drugs306 evidence items

NCIt: C156482

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (892)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 151–175 of 892 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease.
Francesco Mattana, Stefano Luzzago, Valentino Dragonetti et al. · Eur J Nucl Med Mol Imaging · Sep 28, 2026 · PMID 42802268 · candidate dictionary pubmed
Spotlights on Cervical Cancer: Progression, Diagnosis and Clinical Manifestations, Epidemiology, Treatment Approaches, Role of Artificial Intelligence and Future Directions.
Hesham M Tawfeek, Ahmed A H Abddelatif, Hassan Barakat · Drug Dev Ind Pharm · Sep 28, 2026 · PMID 42803760 · candidate dictionary pubmed
Patient-reported outcomes as non-muscle-invasive bladder cancer clinical trial endpoints.
Kimberly Toumazos, Spencer Bell, Katelyn Spencer et al. · BJU Int · Sep 28, 2026 · PMID 42806610 · candidate dictionary pubmed
SEQUENTIAL INTRAVESICAL GEMCITABINE-DOCETAXEL AFTER BCG FAILURE NON-MUSCLE INVASIVE BLADDER CANCER: ONCOLOGICAL OUTCOMES AND SAFETY PROFILE.
Albane Massiet du Biest, Evanguelos Xylinas, Pierre-Etienne Gabriel · Fr J Urol · Sep 28, 2026 · PMID 42805394 · candidate dictionary pubmed
Clinical and MRI characteristics of germline pathogenic variant carriers diagnosed with prostate cancer.
Rory L Cochran, Madhangi Parameswaran, Nabih Nakrour et al. · Eur Radiol · Sep 28, 2026 · PMID 42806037 · candidate dictionary pubmed
Temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggest a window of opportunity for checkpoint inhibitor therapy in prostate cancer.
Anmbreen Jamroze, Renyuan Zhang, Emily Dougherty et al. · J Immunother Cancer · Sep 28, 2026 · PMID 42805760 · candidate

dictionary

pubmed

Differential Association of Post-Testosterone Recovery PSA Kinetics with Progression and Metastatic Outcomes in Non-metastatic Prostate Cancer.

Samuel Lichtman-Mikol, Serageldin Kamel Attia, Yilun Sun et al. · Int J Radiat Oncol Biol Phys · Sep 28, 2026 · PMID 42805409 · candidate dictionary pubmed

Diagnostic performance of 29-MHz micro-ultrasound using cognitive fusion with multiparametric MRI for the detection of clinically significant prostate cancer: a single-center retrospective study.

Cedric Idri, Floriane Michel, Michel Soulie et al. · Fr J Urol · Sep 28, 2026 · PMID 42805393 · candidate dictionary pubmed

Integrated reverse network toxicology and experimental validation identify PTP4A3 as a key target of Benzo[a]pyrene in prostate cancer.

Shiwang Yuan, Jiang Shi, Lin Jiang et al. · Chem Biol Interact · Sep 28, 2026 · PMID 42805285 · candidate dictionary pubmed

Language as a powerful "Influencer" in Prostate Cancer.

Adam B Weiner, Jessica Rett, Scott E Eggener · J Urol · Sep 28, 2026 · PMID 42804927 · candidate dictionary pubmed

FEBE: The female brachytherapy experience. Assessing PTSD symptom rates in women treated for locally advanced cervical cancer with HDR brachytherapy.

Raksha M Narasimhan, Monica Wassel, Emma Herbach et al. · Brachytherapy · Sep 28, 2026 · PMID 42805882 · candidate dictionary pubmed

Modulation of intracellular heme metabolism enhances artesunate-induced cytotoxicity in CD44v-positive cervical cancer cells.

Yoko Ueda, Mieko Tsuji, Minako Mori et al. · Free Radic Biol Med · Sep 28, 2026 · PMID 42805425 · candidate dictionary pubmed

Real-World Landscape of BRCA Deleterious Alterations in Advanced Prostate Cancer: Insights From a Nationwide Genomic Database.

Hideyasu Tsumura, Dai Koguchi, Ken-Ichi Tabata et al. · Prostate · Sep 27, 2026 · PMID 42801735 · candidate dictionary pubmed

Correction to "Gut Parabacteroides distasonis-Derived Indole-3-Acetic Acid Promotes Phospholipid Remodeling and Enhances Ferroptosis Sensitivity via the AhR‒FASN Axis in Bladder Cancer".

· Adv Sci (Weinh) · Sep 27, 2026 · PMID 42801597 · candidate dictionary pubmed

Isocyanate-Modified Melatplatin(IV) Enhances Antitumor Efficacy via TCF4/COL6A3-Mediated Extracellular Matrix Remodeling and cGAS-STING Pathway Activation in Bladder Cancer.

Linhui Wang, Xiaomeng Liu, Tao Zhu et al. · Adv Sci (Weinh) · Sep 27, 2026 · PMID 42801591 · candidate dictionary pubmed

NCCN Risk Groups Do Not Predict Adverse Pathology or Oncologic Outcomes Among Patients With Grade Group 1 Prostate Cancer in the MRI Era.

Eric V Li, Tae-Hee Kim, Michael K Wang et al. · Prostate · Sep 27, 2026 · PMID 42801734 · candidate dictionary pubmed

Is a Few Too Many? Alcohol Consumption and Prostate Cancer Upgrading During Active Surveillance.

Jack Campbell, Michelle I Higgins, Zhuo Tony Su et al. · Prostate · Sep 27, 2026 · PMID 42801731 · candidate dictionary pubmed

Androgen Receptor-Immune Crosstalk in Metastatic Castration-Resistant Prostate Cancer: From Context-Dependent Remodeling to Biomarker-Guided Translation.

Linjie Li, Ruixi Feng, Bingyang Zha et al. · Prostate · Sep 27, 2026 · PMID 42801730 · candidate dictionary pubmed

Insulin-Like Growth Factor Axis and Survival in Metastatic Hormone-Sensitive Prostate Cancer: Post-Hoc Analysis From the ENZAMET Phase 3 Trial.

Michael A Cilento, Hui-Ming Lin, Nicole Yeung et al. · Prostate · Sep 27, 2026 · PMID 42801727 · candidate dictionary pubmed

A Phase II Trial Using Grape Seed Extract for Prostate Cancer Patients With Nonmetastatic Prostate-Specific Antigen Progression After Local Therapy.

Paul Maroni, Tad A Manalo, Hannah Baker et al. · Mol Carcinog · Sep 27, 2026 · PMID 42801665 · candidate dictionary pubmed

Degrading GPX4 via Biomimetic Nanoparticle-Mediated In Situ Synthesis of Deep-Learning-Designed Binder-Degron Chimeras for Prostate Cancer Therapy.

Si-Han Zhang, Ye An, Na Zeng et al. · Adv Sci (Weinh) · Sep 27, 2026 · PMID 42801636 · candidate dictionary pubmed

Dual Compartmentalization of GSTA4 Suppresses Ferroptosis to Drive Antiandrogen Resistance in Prostate Cancer.

Yong Luo, Wei Zhuang, Zean Li et al. · Adv Sci (Weinh) · Sep 27, 2026 · PMID 42801628 · candidate dictionary pubmed

Analysis of NAT2 coding variants, combined genotypes, and haplotypes in prostate cancer susceptibility: a case-control study in an Iraqi Arab population.

Murtadha A Tarish, Bassam K Kudhair · Mol Biol Rep · Sep 27, 2026 · PMID 42801388 · candidate dictionary pubmed

GNAS-AS1 Promotes M2-Like Macrophage Polarization, Contributing to Cervical Cancer Growth, Angiogenesis, and Metastasis Through the miR-518c-5p/FBXO38 Axis and MAPK Signaling.

Lili Zhang, Fang Zhao, Lin Zhang et al. · Mol Carcinog · Sep 27, 2026 · PMID 42801694 · candidate dictionary pubmed

A conotoxin-derived peptide exerts anti-tumor effects in ovarian cancer associated with activation of JNK/JunB signaling.

Jiawei Xu, Zihui Chen, Jianda Yue et al. · Biochem Pharmacol · Sep 27, 2026 · PMID 42801994 · candidate dictionary pubmed